{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:30:56Z","timestamp":1788337856923,"version":"build-2803163510"},"reference-count":23,"publisher":"Japan Oil Chemists' Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Oleo Sci."],"published-print":{"date-parts":[[2024]]},"DOI":"10.5650\/jos.ess23229","type":"journal-article","created":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T22:17:03Z","timestamp":1711923423000},"page":"563-571","source":"Crossref","is-referenced-by-count":3,"title":["Design of an Oral Tablet Containing Furosemide Nanoparticles with Elevated Bioavailability"],"prefix":"10.5650","volume":"73","author":[{"given":"Noriaki","family":"Nagai","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Kindai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Ogata","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Kindai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reita","family":"Kadowaki","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Kindai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Deguchi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Kindai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Otake","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Kindai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Keio University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Misra","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research"},{"name":"Graduate School of Pharmacy, Gujarat Technological University, Gandhinagar Campus Nr. Government Polytechnic K-6 Circle, E-4 Electronic Estate G.I.D.C"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Kindai University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3621","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Boles Ponto, L.L.; Schoenwald, R.D. Furosemide (frusemide). A pharmacokinetic\/pharmacodynamic review (Part I). Clin. Pharmacokinet. 18, 381-408 (1990). doi: 10.2165\/00003088-199018050-00004","DOI":"10.2165\/00003088-199018050-00004"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2) Lindenberg, M.; Kopp, S.; Dressman, J.B. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm. 58, 265-278 (2004). doi: 10.1016\/j.ejpb.2004.03.001","DOI":"10.1016\/j.ejpb.2004.03.001"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Davis, S.S. Formulation strategies for absorption windows. Drug Discov. Today 10, 249-257 (2005). doi: 10.1016\/S1359-6446 (04) 03351-3","DOI":"10.1016\/S1359-6446(04)03351-3"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) Abdelwahed, W.; Degobert, G.; Stainmesse, S.; Fessi, H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv. Drug Deliv. Rev. 58, 1688-1713 (2006). doi: 10.1016\/j.addr.2006.09.017","DOI":"10.1016\/j.addr.2006.09.017"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5) Jog, R.; Burgess, D.J. Pharmaceutical amorphous nanoparticles. J. Pharm. Sci. 106, 39-65 (2017). doi: 10.1016\/j.xphs.2016.09.014","DOI":"10.1016\/j.xphs.2016.09.014"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6) Kumar, S.; Burgess, D.J. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions. Int. J. Pharm. 466, 223-232 (2014). doi: 10.1016\/j.ijpharm.2014.03.021","DOI":"10.1016\/j.ijpharm.2014.03.021"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Keck, C.M.; M\u00fcller, R.H. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur. J. Pharm. Biopharm. 62, 3-16 (2006). doi: 10.1016\/j.ejpb.2005.05.009","DOI":"10.1016\/j.ejpb.2005.05.009"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8) Gao, L.; Zhang, D.; Chen, M. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J. Nanopart. Res. 10, 845-862 (2008). doi: 10.1007\/s11051-008-9357-4","DOI":"10.1007\/s11051-008-9357-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Horn, D.; Rieger, J. Organic nanoparticles in the aqueous phase-theory, experiment, and use. Angew. Chem. Int. Ed. Engl. 40, 4330-4361 (2001). doi: 10.1002\/1521-3773 (20011203) 40:23&lt;4330::aid-anie4330&gt;3.0.co;2-w","DOI":"10.1002\/1521-3773(20011203)40:23<4330::AID-ANIE4330>3.0.CO;2-W"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Rogers, T.L.; Gillespie, I.B.; Hitt, J.E.; Fransen, K.L.; Crowl, C.A. et al. Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs. Pharm. Res. 21, 2048-2057 (2004). doi: 10.1023\/b:pham.00000 48196.61887.e5","DOI":"10.1023\/B:PHAM.0000048196.61887.e5"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11) Nagai, N.; Ogata, F.; Kadowaki, R.; Deguchi, S.; Otake, H. et al. Orally disintegrating tablets containing famotidine nanoparticles provide high intestinal absorbability via the energy-dependent endocytosis pathway. Front. Bioeng. Biotechnol. 11, 1167291. doi: 10.3389\/fbioe.2023.1167291","DOI":"10.3389\/fbioe.2023.1167291"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Deguchi, S.; Ogata, F.; Watanabe, M.; Otake, H.; Yamamoto, N. et al. Nanocrystalline suspensions of irbesartan enhance oral bioavailability by improving drug solubility and leading endocytosis uptake into the intestine. Pharmaceutics 13, 1404 (2021). doi: 10. 3390\/pharmaceutics13091404","DOI":"10.3390\/pharmaceutics13091404"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13) Nagai, N.; Ogata, F.; Otake, H.; Nakazawa, Y.; Kawasaki, N. Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles. Int. J. Nanomedicine 14, 1213-1227 (2019). doi: 10.2147\/IJN.S196681","DOI":"10.2147\/IJN.S196681"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Liu, D.; Yu, S.; Zhu, Z.; Lyu, C.; Bai, C. et al. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: In vitro and in vivo evaluation. Int. J. Pharm. 475, 496-503 (2014). doi: 10.1016\/j.ijpharm. 2014.09.008.","DOI":"10.1016\/j.ijpharm.2014.09.008"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15) Nagai, N.; Ogata, F.; Ike, A.; Shimomae, Y.; Osako, H. et al. Design of oral formulation based on irbesartan nanocrystals increases drug solubility, absorbability, and efficacy. Pharmaceutics 14, 387 (2022). doi: 10.3390\/pharmaceutics14020387","DOI":"10.3390\/pharmaceutics14020387"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16) Otake, H.; Goto, R.; Ogata, F.; Isaka, T.; Kawasaki, N. et al. Fixed-combination eye drops based on fluorometholone nanoparticles and bromfenac\/levofloxacin solution improve drug corneal penetration. Int. J. Nanomedicine 16, 5343-5356 (2021). doi: 10.2147\/IJN.S317046","DOI":"10.2147\/IJN.S317046"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17) Nagai, N.; Iwai, Y.; Sakamoto, A.; Otake, H.; Oaku, Y. et al. Drug delivery system based on minoxidil nanoparticles promotes hair growth in C57BL\/6 mice. Int. J. Nanomedicine 14, 7921-7931 (2019). doi: 10.2147\/IJN.S225496","DOI":"10.2147\/IJN.S225496"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18) Jinno, J.-I.; Kamada, N.; Miyake, M.; Yamada, K.; Mukai, T. et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J. Control. Release 111, 56-64 (2006). doi: 10.1016\/j.jconrel.2005.11.013","DOI":"10.1016\/j.jconrel.2005.11.013"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19) Kumar, S.; Jog, R.; Shen, J.; Zolnik, B.; Sadrieh, N. et al. In vitro and in vivo performance of different sized spray-dried crystalline itraconazole. J. Pharm. Sci. 104, 3018-3028 (2015). doi: 10.1002\/jps.24155","DOI":"10.1002\/jps.24155"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Jog, R.; Burgess, D.J. Comprehensive quality by design approach for stable nanocrystalline drug products. Int. J. Pharm. 564, 426-460 (2019). doi: 10.1016\/j. ijpharm.2019.04.050","DOI":"10.1016\/j.ijpharm.2019.04.050"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Liversidge, G.G.; Cundy, K.C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 125, 91-97 (1995). doi: 10.1016\/0378-5173 (95) 00122-Y","DOI":"10.1016\/0378-5173(95)00122-Y"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Hassan, M.A.; Suleiman, M.S.; Najib, N.M. Improvement of the in vitro dissolution characteristics of famotidine by inclusion in \u03b2-cyclodextrin. Int. J. Pharm. 58, 19-24 (1990). doi: 10.1016\/0378-5173 (90) 90282-9","DOI":"10.1016\/0378-5173(90)90282-9"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23) Patel, J.D.; Patel, K.J. Design and evaluation of famotidine mucoadhesive nanoparticles for aspirin induced ulcer treatment. Braz. Arch. Biol. Technol. 56, 223-236 (2013). doi: 10.1590\/S1516-89132013000200007","DOI":"10.1590\/S1516-89132013000200007"}],"container-title":["Journal of Oleo Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jos\/73\/4\/73_ess23229\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T04:20:55Z","timestamp":1712377255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jos\/73\/4\/73_ess23229\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5650\/jos.ess23229","relation":{},"ISSN":["1345-8957","1347-3352"],"issn-type":[{"value":"1345-8957","type":"print"},{"value":"1347-3352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"ess23229"}}